La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Ontario1445
Stephen J. Kish41
Ontario Sauf Stephen J. Kish" 1431
Stephen J. Kish Sauf Ontario" 27
Ontario Et Stephen J. Kish 14
Ontario Ou Stephen J. Kish 1472
Corpus8669
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 14.
Ident.Authors (with country if any)Title
000595 Yoshiaki Furukawa [Japon] ; Stephen J. Kish [Canada]Parkinsonism in GTP cyclohydrolase 1-deficient DOPA-responsive dystonia.
000F22 Isabelle Boileau [Canada, Niger] ; Doris Payer [Canada] ; Bindiya Chugani [Canada] ; Daniela Lobo [Canada] ; Arian Behzadi [Canada] ; Pablo M. Rusjan [Canada] ; Sylvain Houle [Canada] ; Alan A. Wilson [Canada] ; Jerry Warsh [Canada] ; Stephen J. Kish [Canada] ; Martin Zack [Canada]The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]‐(+)‐propyl‐hexahydro‐naphtho‐oxazin and [11C]raclopride
001104 Amandeep Mann [Canada] ; Sharon L. Miksys ; Andrea Gaedigk ; Stephen J. Kish ; Deborah C. Mash ; Rachel F. TyndaleThe neuroprotective enzyme CYP2D6 increases in the brain with age and is lower in Parkinson's disease patients.
001515 Russell C. Callaghan [Canada] ; James K. Cunningham [États-Unis] ; Jenna Sykes [Canada] ; Stephen J. Kish [Canada]Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs
001537 Julia Sacher [Canada, Allemagne] ; Eugenii A. Rabiner [Canada] ; Michael Clark [Canada] ; Pablo Rusjan [Canada] ; Alexandra Soliman [Canada] ; Rada Boskovic [Canada] ; Stephen J. Kish [Canada] ; Alan A. Wilson [Canada] ; Sylvain Houle [Canada] ; Jeffrey H. Meyer [Canada]Dynamic, adaptive changes in MAO-A binding after alterations in substrate availability: an in vivo [11C]-harmine positron emission tomography study
001C10 Russell C. Callaghan [Canada] ; James K. Cunningham [États-Unis] ; Gautam Sajeev [Canada] ; Stephen J. Kish [Canada]Incidence of Parkinson's disease among hospital patients with methamphetamine‐use disorders
001D28 Stephen J. Kish [Canada] ; Jason Lerch [Canada] ; Yoshiaki Furukawa [Canada, Japon] ; Junchao Ton [Canada] ; Tina Mccluskey [Canada] ; Diana Wilkins [États-Unis] ; Sylvain Houle [Canada] ; Jeffrey Meyer [Canada] ; Emanuela Mundo [Italie] ; Alan A. Wilson [Canada] ; Pablo M. Rusjan [Canada] ; Jean A. Saint-Cyr [Canada] ; Mark Guttman [Canada] ; D. Louis Collins [Canada] ; Colin Shapiro [Canada] ; Jerry J. Warsh [Canada] ; Isabelle Boileau [Canada]Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[11C]DASB and structural brain imaging study
001F26 Isabelle Boileau [Canada, Niger] ; Mark Guttman [Canada] ; Pablo Rusjan [Canada] ; John R. Adams [Canada] ; Sylvain Houle [Canada] ; Junchao Tong [Canada] ; Oleh Hornykiewicz [Autriche] ; Yoshiaki Furukawa [Canada] ; Alan A. Wilson [Canada] ; Shitij Kapur [Canada] ; Stephen J. Kish [Canada]Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naïve Parkinson's disease
002179 Isabelle Boileau [Canada] ; Pablo Rusjan ; Sylvain Houle ; Diana Wilkins ; Junchao Tong ; Peter Selby ; Mark Guttman ; Jean A. Saint-Cyr ; Alan A. Wilson ; Stephen J. KishIncreased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: Is VMAT2 a stable dopamine neuron biomarker?
002329 Isabelle Boileau [Canada] ; Jerry J. Warsh [Canada] ; Mark Guttman [Canada] ; Jean A. Saint-Cyr [Canada] ; Tina Mccluskey [Canada] ; Pablo Rusjan [Canada] ; Sylvain Houle [Canada] ; Alan A. Wilson [Canada] ; Jeffrey H. Meyer [Canada] ; Stephen J. Kish [Canada]Elevated serotonin transporter binding in depressed patients with Parkinson's disease: A preliminary PET study with [11C]DASB
002D90 Mark Guttman [Canada] ; Stephen J. Kish ; Yoshiaki FurukawaCurrent concepts in the diagnosis and management of Parkinson's disease.
003978 Kelly Macmillan Muenter [États-Unis] ; Lysia S. Forno [États-Unis] ; Oleh Hornykiewicz [Autriche] ; Stephen J. Kish [Canada] ; Demetrius M. Maraganore [États-Unis] ; Richard J. Caselli [États-Unis] ; Haruo Okazaki [États-Unis] ; Frank M. Howard Jr. [États-Unis] ; Barry J. Snow [Nouvelle-Zélande] ; Donald B. Calne [Canada]Hereditary form of parkinsonism—dementia
003E41 Michel P. Furukawa [Japon, Canada] ; Mitsunobu Shimadzu [Japon] ; Ali H. Rajput [Canada] ; Yumiko Shimuzu [Japon] ; Tetsuzo Tagawa [Japon] ; Hideo Mori [Japon] ; Masayuki Yokochi [Japon] ; Hirotaro Narabayashi [Japon] ; Oleh Hornykiewicz [Autriche] ; Yoshikuni Mizuno [Japon] ; Stephen J. Kish [Canada]GTP‐cyclohydrolase I gene mutations in hereditary progressive and dopa‐responsive dystonia
004C30 Douglas S. Gilbert [Canada] ; Stephen J. Kish [Canada] ; Li-Jan Chang [Canada] ; Caryl Morito [Canada] ; Kathleen Shannak [Canada] ; Oleh Hornykiewicz [Canada, Autriche]Dementia, parkinsonism, and motor neuron disease: Neurochemical and neuropathological correlates

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022